Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Anta Sports Expands Global Footprint With Strategic Puma Stake
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Thailand Inflation Remains Negative for 10th Straight Month in January
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations 



